Sprinklr reported lower Q1 FY25 results, with sales of $196.0M and adjusted EPS of $0.09 beating consensus. Co-CEO appointed and share buyback announced.
– Data Show Encouraging Signals for Vidofludimus Calcium for Preventing or Delaying Confirmed Disability Worsening –
– Virtual Multiple Sclerosis R&D Day to be Held Today, November 17,